Children with hematologic malignancies continue to exhibit increased IPD risk despite an overall decline in pediatric IPD after the introduction of the PCV13 vaccine.

Merck MRK announced a definitive agreement to acquire Verona Pharma VRNA for approximately $10 billion. The deal will add ...

A large surveillance study suggests that an extra pneumococcal vaccine dose for new care home residents can significantly ...

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...

Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines, taking a 21-valent shot licensed from SK Biosciences into phase 3 testing. The ...

Korea has developed the world's first recombinant protein-based anthrax vaccine, a major step toward self-sufficiency that could also open export markets for the new vaccine with fewer side effects, ...

Less than 24 hours after Kennedy announced that HHS had removed all of CDC's vaccine advisors, American Medical Association (AMA) delegates passed an emergency resolution urging Kennedy to reverse ...

Check out our PLTR stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.